64
Participants
Start Date
February 28, 2011
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
ABT-888 and mFOLFOX-6
ABT-888 in escalating doses twice a day for Days 1-7 of each 14-day cycle Oxaliplatin 85 mg/M2 IV on Day 1 Leucovorin 400 mg/m2 IV on Day 1 5-FU 400 mg/m2 IV bolus followed by 2400 mg/m2 IV continuous infusion over 46 hours Days 1-3
Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Collaborators (1)
Abbott
INDUSTRY
Georgetown University
OTHER